Active Clinical Trials
At any given time, COG supports close to 100 active studies and enrolls approximately 12,000 patients each year across more than 200 hospitals worldwide, ensuring broad access to participation. COG trials span nearly all pediatric cancers, including leukemia, lymphoma, brain tumors, sarcomas, and rare diseases. By integrating treatment, biology, supportive care, and survivorship studies, COG’s current trial portfolio is designed to both improve cure rates and reduce long-term harm for children and adolescents with cancer.